These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32998853)

  • 1. Pentoxifylline and tocopherol protocol to treat medication-related osteonecrosis of the jaw: A systematic literature review.
    Cavalcante RC; Tomasetti G
    J Craniomaxillofac Surg; 2020 Nov; 48(11):1080-1086. PubMed ID: 32998853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the use of Pentoxifylline and Tocopherol effective in the treatment of Osteoradionecrosis of the jaws or for the treatment of medicationosteonecrosis of the jaw? An overview.
    de Morais RPL; de Aguiar AWPB; da Hora Sales PH; Carvalho AAT; Vescovi P; Meleti M; Leão JC
    J Stomatol Oral Maxillofac Surg; 2024 Sep; 125(5S1):101959. PubMed ID: 38964469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The PENTO protocol in medication-related osteonecrosis of the jaw: A single-center phase IIa trial].
    Dumur A; Pages E; Brie J; Laloze J; Usseglio J
    Bull Cancer; 2024 May; 111(5):537-538. PubMed ID: 38609796
    [No Abstract]   [Full Text] [Related]  

  • 4. Sclerotic bone: a sign of bone reaction in patients with medication related osteonecrosis of the jaw.
    Obermeier KT; Dewenter I; Malenova Y; Fliefel R; Kaeppler G; Otto S
    Sci Rep; 2024 Apr; 14(1):7914. PubMed ID: 38575664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of double-layer soft tissue suture closure technique in the surgical treatment of patients with mandible medication-related osteonecrosis of the jaw of early and medium stages].
    Zhou Y; Zhao N; Huang H; Li Q; Guo C; Guo Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 56(1):51-56. PubMed ID: 38318896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication-Related Osteonecrosis of the Jaw in Cancer Patients: Result from the OneFlorida Clinical Research Consortium.
    Yang G; Williams R; Wang L; Farhadfar N; Chen Y; Loiacono AT; Bian J; Holliday LS; Katz J; Gong Y
    J Bone Miner Res; 2022 Dec; 37(12):2466-2471. PubMed ID: 36151778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HMGB1/RAGE Signaling Reduces the Incidence of Medication-Related Osteonecrosis of the Jaw (MRONJ) in Mice.
    Gkouveris I; Hadaya D; Elzakra N; Soundia A; Bezouglaia O; Dry SM; Pirih F; Aghaloo T; Tetradis S
    J Bone Miner Res; 2022 Sep; 37(9):1775-1786. PubMed ID: 35711109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication-related osteonecrosis of the jaw (MRONJ): a review of pathogenesis hypothesis and therapy strategies.
    Jiang A; Zhang Z; Qiu X; Guo Q
    Arch Toxicol; 2024 Mar; 98(3):689-708. PubMed ID: 38155341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication-related osteonecrosis (MRONJ) of the mandible and maxilla.
    Dunphy L; Salzano G; Gerber B; Graystone J
    BMJ Case Rep; 2020 Jan; 13(1):. PubMed ID: 31907213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication-Related Osteonecrosis of the Jaw (MRONJ): Are Antiresorptive Drugs the Main Culprits or Only Accomplices? The Triggering Role of Vitamin D Deficiency.
    Dalle Carbonare L; Mottes M; Valenti MT
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33567797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication-related Osteonecrosis of the Jaw Induced by Regenerative Therapy in Implant Dentistry: A Scoping Review.
    Al-Omari FA; Kuroshima S; Sawase T
    J Dent; 2023 Nov; 138():104682. PubMed ID: 37708930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pembrolizumab related osteonecrosis of the jaw.
    Patel V; Carey B
    Br J Oral Maxillofac Surg; 2023 Dec; 61(10):704-706. PubMed ID: 37957097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication-related osteonecrosis of the jaw: evolving research for multimodality medical management.
    Abdolrahmani A; Epstein JB; Samim F
    Support Care Cancer; 2024 Mar; 32(4):212. PubMed ID: 38443685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical treatment of severe medication-related osteonecrosis of the jaw.
    Feng Z; An J; Zhang Y; He Y
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2023 Feb; 41(1):43-51. PubMed ID: 38596940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Navigating the complexities and controversies of medication-related osteonecrosis of the jaw (MRONJ): a critical update and consensus statement.
    Coropciuc R; Moreno-Rabié C; De Vos W; Van de Casteele E; Marks L; Lenaerts V; Coppejans E; Lenssen O; Coopman R; Walschap J; Nadjmi N; Jacobs R; Politis C; Van den Wyngaert T
    Acta Chir Belg; 2024 Feb; 124(1):1-11. PubMed ID: 38059301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple myeloma identified within the same site of the mandible with medication-related osteonecrosis of jaw: An unusual case report.
    Wu XH; Chen SW
    Medicine (Baltimore); 2023 Jul; 102(29):e34260. PubMed ID: 37478232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The assessment of halitosis with a new screening tool in medication-related osteonecrosis of the jaw.
    Choi Y; Kim J; Rhee Y; Park JH; Nam W; Park W
    Clin Oral Investig; 2024 Jan; 28(1):102. PubMed ID: 38233664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of daily versus weekly teriparatide for medication-related osteonecrosis of the jaw: A case-control study.
    Kim KM; Kim S; Hwang H; Kim HY; Kim D; Park JH; Choo H; Kim JW
    Oral Dis; 2024 Jul; 30(5):3286-3295. PubMed ID: 37927178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative clinical study of phosphorous necrosis and medical-related osteonecrosis of the jaws.
    Xie R; Wang W; Bian L; Qian Y; Li J; Zhang H
    Clin Oral Investig; 2024 Feb; 28(2):147. PubMed ID: 38351377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reporting Criteria for Clinical Trials on Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review and Recommendations.
    Gaudet C; Odet S; Meyer C; Chatelain B; Weber E; Parmentier AL; Derruau S; Laurence S; Mauprivez C; Brenet E; Kerdjoudj H; Fenelon M; Fricain JC; Zwetyenga N; Hoarau D; Curien R; Gerard E; Louvrier A; Gindraux F
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.